Can AMH Levels Distinguish LOCAH from PCOS Among Hirsute Women?

    April 2014 in “ European Journal of Obstetrics & Gynecology and Reproductive Biology ”
    Mahmut Oncul, Sezai Sahmay, Abdullah Tüten … Hazel Gurleyen
    Studysummary This study concluded that antimullerian hormone levels are not generally effective for distinguishing late onset congenital adrenal hyperplasia from all hyperandrogenic polycystic ovary syndrome subtypes, except one specific subtype.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ejog.org →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Non-Classic Congenital Adrenal Hyperplasia Steroids · 2013
    2. Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome Experimental and Clinical Endocrinology & Diabetes · 2012
    3. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline The Journal of Clinical Endocrinology and Metabolism · 2006
    4. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients The Journal of Clinical Endocrinology and Metabolism · 2004
    5. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS) Human Reproduction · 2003
    6. The Evaluation and Management of Hirsutism Obstetrics and gynecology (New York. 1953. Online)/Obstetrics and gynecology · 2003
    7. Screening for 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia Among Hyperandrogenic Women: A Prospective Study Fertility and Sterility · 1999
    8. Classification of the Types of Androgenetic Alopecia (Common Baldness) Occurring in the Female Sex British Journal of Dermatology · 1977